Form D · Biotechnology

Entopsis, Inc.

Medley, FL · CIK 0001634457

Offering snapshot reported Oct 19, 2023 · SEC filing

Reported sold
Yet to sell
Offering amount: $6M
Investors reported
0
Form D · investor count
Minimum accepted
$25K
Reported outside-investor minimum
First sale
Yet to occur
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Oct 19, 2023InitialYet to sellNo comparison0SEC filing
Mar 1, 2021Initial$1,040,000No comparison9SEC filing
Jan 10, 2017Initial$250,000No comparison2SEC filing
Mar 19, 2015Initial$575,000No comparison5SEC filing

Offering details

Securities
Equity
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-495167

Source: Form D, filed Oct 19, 2023. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Rohit Bawa Executive
Ian Cheong Director, Executive
Chun Yi George Huang Director, Executive
George Huang Executive
Leonard Nannarone Executive
Obdulio Piloto Director, Executive
Pratik Sharma Executive

Issuer details

Industry: Biotechnology (See others in industry)

Address:
7600 Nw 69 Th Avenue
Medley, FL, 33166